On March 1, 2026, RBI Strategies & Research completed a survey for Centennial State Prosperity of 600 likely
voters in the November general election in Colorado. The results reveal:
- 67% of Coloradans — across party lines — support the work and purpose of Colorado’s Prescription Drug
Affordability Board (PDAB), - Coloradans want the PDAB to be more proactive in limiting prescription drug costs in the State, and
- Coloradans have an overwhelmingly unfavorable view of big pharmaceutical companies.
The Senate Health and Human Services Committee is set to hear SB26-140 on Thursday, which will severely limit the PDAB by preventing it from reviewing the cost of hundreds of commonly-prescribed medications that Coloradans struggle to afford every day. CSP’s poll shows — less than 5 years after the bill to create the PDAB was passed — over 2/3 of Coloradans continue to support the work of Colorado’s PDAB to lower prescription medication costs.
You can read the full poll memo here.